Saccharin

Saccharin

SCHEMBL4425845

O=C1NS(=O)(=O)c2ccccc21.c1ccc(-c2ccccc2)cc1

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 9/20 0.85
CA9 Q16790 9/20 0.85
CA2 P00918 8/20 0.85
CA1 P00915 3/20 0.85
CA4 P22748 2/20 0.85
CA7 P43166 2/20 0.85
KDM4E B2RXH2 1/20 0.85
USP2 O75604 1/20 0.85
LMNA P02545 1/20 0.85
BCHE P06276 1/20 0.85
CA6 P23280 1/20 0.85
CA5A P35218 1/20 0.85
KMT2A Q03164 1/20 0.85
CA14 Q9ULX7 1/20 0.85
CA5B Q9Y2D0 1/20 0.85
ALDH1A1 P00352 2/20 0.54
PTGES O14684 1/20 0.51
PTGS2 P35354 1/20 0.51
HSD11B1 P28845 1/20 0.50
ALPL P05186 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Saccharin SCHEMBL28045129 0.92 CA12 (0.92) CA12CA9CA2CA1CA4
Saccharin SCHEMBL27905604 0.92 CA12 (0.92) CA12CA9CA2CA1CA4
Saccharin SCHEMBL29109711 0.92 CA12 (0.92) CA12CA9CA2CA1CA4
Saccharin SCHEMBL29191365 0.92 CA12 (1.00) CA12CA9CA2CA1CA4
Saccharin SCHEMBL7073018 0.92 CA12 (1.00) CA12CA9CA2CA1CA4
Saccharin SCHEMBL29358404 0.92 CA12 (1.00) CA12CA9CA2CA1CA4
Saccharin SCHEMBL3816 0.92 CA12 (1.00) CA12CA9CA2CA1CA4
Saccharin SCHEMBL6033672 0.92 CA12 (1.00) CA12CA9CA2CA1CA4
Saccharin SCHEMBL588640 0.92 CA12 (1.00) CA12CA9CA2CA1CA4
Saccharin SCHEMBL4777123 0.92 CA12 (1.00) CA12CA9CA2CA1CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8357671-B2 High affinity Siglec ligands Paulson, James (US) 2013-01-22 US disclosed
US-20090238837-A1 High Affinity Siglec Ligands NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-09-24 US disclosed
EP-1951740-A2 HIGH AFFINITY SIGLEC LIGANDS Paulson, James (US) 2008-08-06 EP disclosed
WO-2007056525-A2 HIGH AFFINITY SIGLEC LIGANDS PAULSON JAMES (US) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090238837-A1 High Affinity Siglec Ligands SIGLEC7, SIGLEC9, FCGR1A CA12 1037/4885CA9 2015/4885CA2 3558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.